Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 20/20 | 0.62 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3566409 | 1.00 | NR1H4 (0.62) | NR1H4KCNH2CYP3A4CYP2D6CYP2C9 | |
| Hydrochloric Acid SCHEMBL3567619 | 0.86 | NR1H4 (0.68) | NR1H4KCNH2CYP3A4CYP2D6CYP2C9 | |
| Hydrochloric Acid SCHEMBL29881259 | 0.86 | NR1H4 (0.68) | NR1H4KCNH2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL3565853 | 0.86 | NR1H4 (0.67) | NR1H4KCNH2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL29880729 | 0.86 | NR1H4 (0.67) | NR1H4KCNH2CYP3A4CYP2D6CYP2C9 | |
| Hydrochloric Acid SCHEMBL3567618 | 0.85 | NR1H4 (0.69) | NR1H4KCNH2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL29881174 | 0.83 | NR1H4 (0.70) | NR1H4KCNH2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL3572447 | 0.83 | NR1H4 (0.70) | NR1H4KCNH2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL29880733 | 0.82 | NR1H4 (0.68) | NR1H4KCNH2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL3563864 | 0.82 | NR1H4 (0.68) | NR1H4KCNH2CYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110404073-B | Methods and pharmaceutical compositions for treating hepatitis B virus infection | 国家医疗保健研究所 | 2022-08-16 | — | — | CN | disclosed |